Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial

Controlled Trial ◽

Phase 2 ◽

Dengue Vaccine ◽

Double Blind ◽

Faculty Opinions recommendation of The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955094.793462652 ◽

2012 ◽

Author(s):

Chim Lang

Keyword(s):

Heart Failure ◽

Controlled Trial ◽

Preserved Ejection Fraction ◽

Phase 2 ◽

Angiotensin Receptor ◽

Double Blind ◽

Neprilysin Inhibitor ◽

Angiotensin Receptor Neprilysin Inhibitor ◽

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(12)61227-6 ◽

2012 ◽

Vol 380 (9851) ◽

pp. 1387-1395 ◽

Cited By ~ 637

Author(s):

Scott D Solomon ◽

Michael Zile ◽

Burkert Pieske ◽

Adriaan Voors ◽

Amil Shah ◽

...

Keyword(s):

Heart Failure ◽

Controlled Trial ◽

Preserved Ejection Fraction ◽

Phase 2 ◽

Angiotensin Receptor ◽

Double Blind ◽

Neprilysin Inhibitor ◽

Angiotensin Receptor Neprilysin Inhibitor ◽

Treatment efficacy of azithromycin 1 g single dose versus doxycycline 100 mg twice daily for 7 days for the treatment of rectal chlamydia among men who have sex with men – a double-blind randomised controlled trial protocol

BMC Infectious Diseases ◽

10.1186/s12879-016-2125-7 ◽

2017 ◽

Vol 17 (1) ◽

Cited By ~ 14

Author(s):

Andrew Lau ◽

Fabian Kong ◽

Christopher K. Fairley ◽

Basil Donovan ◽

Marcus Chen ◽

...

Keyword(s):

Single Dose ◽

Treatment Efficacy ◽

Controlled Trial ◽

Trial Protocol ◽

Double Blind ◽

Sex With Men ◽

Effect of single dose intravenous tranexamic acid on blood loss in tangential excision of burn wounds — a double blind randomised controlled trial

Burns ◽

10.1016/j.burns.2021.08.021 ◽

2021 ◽

Author(s):

Ajai K.S. ◽

Parmod Kumar ◽

Mohsina Subair ◽

Ramesh Kumar Sharma

Keyword(s):

Single Dose ◽

Blood Loss ◽

Tranexamic Acid ◽

Controlled Trial ◽

Double Blind ◽

Burn Wounds ◽

Single‐dose azithromycin versus seven days of amoxycillin in the treatment of acute otitis media in Aboriginal children (AATAAC): a double blind, randomised controlled trial

The Medical Journal of Australia ◽

10.5694/j.1326-5377.2010.tb03396.x ◽

2010 ◽

Vol 192 (1) ◽

pp. 24-29 ◽

Cited By ~ 18

Author(s):

Peter S Morris ◽

Gaudencio Gadil ◽

Gabrielle B McCallum ◽

Cate A Wilson ◽

Heidi C Smith‐Vaughan ◽

...

Keyword(s):

Single Dose ◽

Otitis Media ◽

Controlled Trial ◽

Acute Otitis Media ◽

Double Blind ◽

Randomised Controlled ◽

Aboriginal Children

Does a single dose of intravenous dexamethasone reduce Symptoms in Emergency department patients with low Back pain and RAdiculopathy (SEBRA)? A double-blind randomised controlled trial

Emergency Medicine Journal ◽

10.1136/emermed-2013-203490 ◽

2014 ◽

Vol 32 (7) ◽

pp. 525-530 ◽

Cited By ~ 11

Author(s):

Ravichandra Balakrishnamoorthy ◽

Isabelle Horgan ◽

Siegfried Perez ◽

Michael Craig Steele ◽

Gerben B Keijzers

Keyword(s):

Emergency Department ◽

Low Back Pain ◽

Single Dose ◽

Back Pain ◽

Controlled Trial ◽

Low Back ◽

Double Blind ◽

Emergency Department Patients ◽

Faculty Opinions recommendation of The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955094.793467314 ◽

2012 ◽

Author(s):

Jerome Fleg

Keyword(s):

Heart Failure ◽

Controlled Trial ◽

Preserved Ejection Fraction ◽

Phase 2 ◽

Angiotensin Receptor ◽

Double Blind ◽

Neprilysin Inhibitor ◽

Angiotensin Receptor Neprilysin Inhibitor ◽

A MULTICENTRE DOUBLE-BLIND RANDOMISED CONTROLLED TRIAL TO ASSESS THE CLINICAL- AND COST-EFFECTIVENESS OF FACET-JOINT INJECTIONS IN PATIENTS WITH NON-SPECIFIC LOW BACK PAIN: A FEASIBILITY STUDY

10.26226/morressier.59ad4811d462b80290b53a8a ◽

2017 ◽

Author(s):

Ahmad Alia

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Cost Effectiveness ◽

Facet Joint ◽

Controlled Trial ◽

Low Back ◽

Double Blind ◽

Randomised Controlled ◽

Joint Injections

Faculty Opinions recommendation of TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1058963.510919 ◽

2007 ◽

Author(s):

Pascal Derkinderen

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Double Blind ◽

Faculty Opinions recommendation of Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718482844.793498728 ◽

2014 ◽

Author(s):

Carlos Seas ◽

Joel Lopez

Keyword(s):

Controlled Trial ◽

Double Blind ◽